Flagship’s Ampersand Bio Adds $65M to Solve One of the Top Challenges in Medicine
Ampersand Biomedicines’ map of all tissue in the human body reveals “addresses,” identifying markers on disease targets that are not found on healthy tissue. The company aims to improve the targeting of biologic drugs in order to reduce on-target, off-tissue toxicity. The post Flagship’s Ampersand Bio Adds $65M to Solve One of the Top Challenges in Medicine appeared first on MedCity News.
Ampersand Biomedicines’ map of all tissue in the human body reveals “addresses,” identifying markers on disease targets that are not found on healthy tissue. The company aims to improve the targeting of biologic drugs in order to reduce on-target, off-tissue toxicity.
The post Flagship’s Ampersand Bio Adds $65M to Solve One of the Top Challenges in Medicine appeared first on MedCity News.
